Related Experiment Video
Updated: Jul 28, 2026
07:52
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
Published on: June 2, 2015
Ischemic preconditioning mediated angiogenic response in the heart
1Molecular Cardiology Laboratory, Department of Surgery, University of Connecticut Medical Center, Farmington, CT, USA. nmaulik@neuron.uchc.edu
Antioxidants & Redox Signaling
|March 18, 2004
Summary
Ischemic preconditioning, a brief episode of low blood flow, triggers angiogenesis. This process enhances blood vessel growth, improving heart tissue survival after artery blockage, offering new therapeutic avenues.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Regenerative Medicine
Background:
- Angiogenesis is crucial for treating diseases like cancer and ischemic cardiovascular disease.
- Therapeutic angiogenesis via proteins or gene therapy is a promising treatment for ischemic heart disease.
- Understanding how ischemia induces angiogenesis is key for developing new therapies.
Purpose of the Study:
- To explore the signaling mechanisms behind angiogenesis induced by ischemic preconditioning.
- To identify how this preconditioning improves myocardial salvage after coronary artery occlusion.
Main Methods:
- This review synthesizes existing research on ischemic preconditioning and angiogenesis.
- It focuses on identifying key signaling pathways involved.
Main Results:
- Ischemic preconditioning activates specific signaling cascades that promote blood vessel formation.
- These pathways contribute to enhanced survival of heart muscle tissue.
Conclusions:
- Ischemic preconditioning is a potent stimulus for therapeutic angiogenesis in the heart.
- Targeting these signaling mechanisms could lead to novel treatments for ischemic heart disease.
Related Concept Videos
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...